The hypoxia-driven mechanism described in this study that occurrs in a pathological SMC phenotype prevalent in advanced atherosclerotic plaques [8–10], may explain why EPAC1 outperforms current biomarkers in diagnosing severe CAD. Here, RAPGEF3 is linked to coronary artery disorder.